FOXM1 and familial pancreatic carcinoma: To further assess the effect of FOXM1 on the sensitivity of pancreatic cancer cells to chemotherapy, we generated human pancreatic cancer cells that overexpressed FOXM1 (BxPC3-FOXM1) and cells in which FOXM1 had been knocked out by CRISPR/Cas9 (SW1990-KO).